The High Court has ruled that the government must determine the prices of all life-saving drugs manufactured in Bangladesh. The verdict was delivered on Monday (August 25) by a High Court bench comprising Justice Md. Rezaul Hasan and Justice Bishwajit Debnath.
Previously, the government set the prices for 739 types of life-saving drugs. However, in 1993, a government notification reduced this number to 177 drugs, limiting the government’s authority to regulate their prices. The High Court has now declared that notification illegal and void.
In 2018, a human rights organization named Human Rights and Peace for Bangladesh challenged the 1993 notification by filing a writ petition in the High Court.
Senior Advocate Manzil Morshed, the lawyer for the petitioner, stated that the authority to set prices of life-saving drugs had been handed over to private pharmaceutical manufacturers, forcing the general public to purchase these drugs at higher prices. On August 17, the interim government formed a taskforce to compile a new list of life-saving drugs. The High Court has directed that the prices of all drugs included in this list must be determined by the government.
Note For Readers:
The CEO handles all legal and staff issues. Claiming human help before the first hearing isn't part of our rules.
Our system uses humans and AI, including freelance journalists, editors, and reporters.
The CEO can confirm if your issue involves a person or AI.
by 
